Skip to main content

Table 2 Summary of self-reported comfort scores rated on a 10-point VAS at 48 h post-treatment comparing treatment (Floseal® (Baxter, USA)) to control (traditional packing methods)

From: Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial

Pain Treatment (Floseal) (N = 13) Control (N = 13) Z-score p-valuea
Placement 2.4 7.8 3.6987 0.0022
Treatment 0.5 4.5 3.3800 0.0007
Removal 0 3.9 3.0699 0.0021
  1. a α = 0.05, significant results in bold using unpaired Mann-Whitney U test; mean 10-pt VAS of patient pain experienced (0 = no pain, 10 = worst pain ever experienced)